XML 38 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Cash flows from operating activities:    
Net income (loss) $ 13,942 $ (6,300)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:    
Amortization of bond premium or discount 958 1,084
Net realized (gain) loss on sale of investments (416) (13)
Unrealized (gain) loss on trading securities 368 4,587
Equity-based compensation expense 373 92
Changes in assets and liabilities:    
Accrued investment income 190 (81)
Other assets 401 71
Change in cash held in trust 26,478 5,600
Change in restricted cash (79,755) 22,080
Losses and loss adjustment reserves (20,652) (16,496)
Losses payable (1,717) (159)
Unearned premiums (167) 1,424
Accrued ceding commission expense (51) (24)
Accrued interest on notes payable 30 (215)
Loss contract fair market value reserve (30,287) (987)
Other liabilities (761) (98)
Total adjustments (105,008) 16,865
Net cash (used in) provided by operating activities: (91,066) 10,565
Cash flows from investing activities:    
Purchase of investments (341,313) (179,769)
Proceeds from sales and maturities of investments 412,164 180,976
Net cash provided by investing activities: 70,851 1,207
Cash flows from financing activities:    
Proceeds from issuance of preferred stock 11,072  
Fees incurred preferred stock issuance (1,617)  
Proceeds from sale of warrants to purchase common stock 11,500  
Fees incurred relating to warrants issued (1,617)  
Deferred offering costs (12,048)  
Notes payable - principal repayments   (21,282)
Notes payable - principal issued 2,763 1,445
Net cash provided by (used in) financing activities: 10,053 (19,837)
Decrease in cash and cash equivalents (10,162) (8,065)
Cash and cash equivalents, beginning of period 11,986 16,761
Cash and cash equivalents, end of period 1,824 8,696
Cash paid during the period:    
Interest 4,157 6,744
Supplementary disclosure of non-cash investing and financing activities:    
Notes payable issued in lieu of cash interest payments 2,763 1,445
Preferred deemed dividend recorded due to beneficial conversion feature $ 9,455